Sorin takes on Japan Lifeline for CRM (cardiac rhythm management) devices in Japan
This article was originally published in Clinica
Executive Summary
Milan, Italy-based Sorin Group has further boosted its presence in the Japanese cardiology market by signing a ten-year partnership agreement with medical device distributor Japan Lifeline (JLL) to market its cardiac rhythm management (CRM) devices. JLL already distributes Sorin's Carbomedics heart valves. The partnership will become effective as of September 1 2007. By combining the sales efforts of its own Japanese subsidiary with that of JLL, Sorin hopes to increase its penetration of Japan, where over 50,000 pacemakers and 3,500 defibrillators were implanted in 2006.
You may also be interested in...
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.